| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website http://www.jocmr.org |
Letter to the Editor
Volume 12, Number 6, June 2020, pages 389-392
A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients
Tables
| All patients | Severe patients | Non-severe patients | P value | |
|---|---|---|---|---|
| P values indicate a statistically significant difference between severe and non-severe patients. NA: not available; COVID-19: coronavirus disease 2019. | ||||
| Huang et al, 2020 [2] | 8/41 (20%) | 1/13 (8%) | 7/28 (25%) | 0.16 |
| Zhang et al, 2020 [3] | 17/140 (12.1%) | 8/58 (13.8%) | 9/82 (11%) | 0.615 |
| Wang et al, 2020 [4] | 14/138 (10.1%) | 8/36 (22.2%) | 6/102 (5.9%) | 0.009 |
| Wu et al, 2020 [5] | 22/201 (10.9%) | 16/84 (19%) | 6/117 (5.1%) | 0.002 |
| Zhou et al, 2020 [1] | 36/191 (19%) | 17/54 (31%) | 19/137 (14%) | 0·0051 |
| Wan et al, 2020 [6] | 12/135 (8.9%) | 9/40 (22.5%) | 3/95 (3.1%) | NA |
| Guan et al, 2020 [7] | 30/1,590 (8.2%) | 19/130 (14.6%) | 80/1,460 (5.5%) | NA |
| Wang et al, 2020 [8] | 54/339 (16%) | 11/65 (17.2%) | 43/274 (15.8%) | 0.116 |
| Chen et al, 2020 [9] | 14/145 (9.7%) | 7/43 (16.3%) | 7/102 (6.9%) | 0.08 |
| Hu et al, 2020 [10] | 47/323 (14.6%) | 11/26 (42.3%) | 14/151 (9.3%) | < 0.001 |
| Itelman et al, 2020 [11] | 30/162 (18.5%) | 11/92 (30.8%) | 8/26 (12%) | 0.04 |
| Huang et al, 2020 [12] | 19/202 (9.4%) | 8/23 (34.8%) | 11/179 (6.1%) | < 0.001 |
| All patients | Severe patients | Non-severe patients | P value | |
|---|---|---|---|---|
| P values indicate a statistically significant difference between severe and non-severe patients. NA: not available; COVID-19: coronavirus disease 2019. | ||||
| Huang et al, 2020 [2] | 6/41 (15%) | 2/13 (15%) | 4/28 (14%) | 0.93 |
| Zhang et al, 2020 [3] | 42/140 (30%) | 22/58 (37.9%) | 20/82 (24.4%) | 0.085 |
| Wang et al, 2020 [4] | 43/138 (31.2%) | 21/36 (58.3%) | 22/102 (21.6%) | < 0.001 |
| Wu et al, 2020 [5] | 39/201 (19.4%) | 23/84 (27.4%) | 16/117 (13.7%) | 0.02 |
| Zhou et al, 2020 [1] | 58/191 (30%) | 26/54 (48%) | 32/137 (23%) | 0·0008 |
| Wan et al, 2020 [6] | 13/135 (9.6%) | 4/40 (10%) | 9/95 (9.4%) | NA |
| Guan et al, 2020 [7] | 269/1,590 (16.9%) | 38/269 (14.1%) | 61/1,321 (4.6%) | NA |
| Wang et al, 2020 [8] | 138/339 (40.8%) | 32/65 (50%) | 106/274 (38.8%) | 0.031 |
| Chen et al, 2020 [9] | 22/145 (15.2%) | 9/43 (20.9%) | 13/102 (12.7%) | 0.21 |
| Hu et al, 2020 [10] | 105/323 (32.5%) | 10/26 (38.5%) | 39/151 (25.8%) | 0.056 |
| Itelman et al, 2020 [11] | 49/162 (30.2%) | 13/26 (50%) | 18/92 (19.6%) | 0.002 |
| Huang et al, 2020 [12] | 29/202 (14.4%) | 2/23 (8.7%) | 27/179 (15.1%) | 0.411 |
| All patients | Severe patients | Non-severe patients | P value | |
|---|---|---|---|---|
| P values indicate a statistically significant difference between severe and non-severe patients. NA: not available; COVID-19: coronavirus disease 2019. | ||||
| Huang et al, 2020 [2] | 6/41 (15%) | 3/13 (23%) | 3/28 (11%) | 0.32 |
| Zhang et al, 2020 [3] | 7/140 (5%) | 4/58 (6.9%) | 3/82 (3.7%) | 0.448 |
| Wang et al, 2020 [4] | 20/138 (14.5%) | 9/36 (25%) | 11/102 (10.8%) | 0.04 |
| Wu et al, 2020 [5] | 8/201 (4%) | 5/84 (6%) | 3/117 (2.6%) | 0.4 |
| Zhou et al, 2020 [1] | 15/191 (8%) | 13/54 (24%) | 2/137 (1%) | < 0.0001 |
| Wan et al, 2020 [6] | 7/135 (5.2%) | 6/40 (15%) | 1/95 (1%) | NA |
| Guan et al, 2020 [7] | 59/1,590 (3.7%) | 8/59 (13.6%) | 91/1,531 (5.9%) | NA |
| Wang et al, 2020 [8] | 53/339 (14.2%) | 21/65 (32.8%) | 32/274 (11.7%) | < 0.001 |
| Hu et al, 2020 [10] | 41/323 (12.7%) | 11/26 (42.3%) | 8/151 (5.3%) | < 0.001 |
| Itelman et al, 2020 [11] | 12/162 (7.4%) | 4/26 (15.4%) | 5/92 (5.4%) | 0.228 |
| Huang et al, 2020 [12] | 5/202 (2.5%) | 1/23 (4.3%) | 4/179 (2.2%) | 0.539 |